Non-Allergic Rhinitis (NAR) is a heterogeneous disease, characterized by nasal hyperreactivity that results in typical symptoms due to irritation, such as rhinorrhoea and sneezing, and/or due to vasodilatation obstruction. Diagnosis of NAR is based on persistent symptoms throughout the year after exclusion of infection, any anatomical or medical disorder, and absence of serum IgE specific to relevant aeroallergens (1) (2) (3) (4) .
The aetiology of NAR is largely unknown for a majority of about 75-80% of the patients and NAR is classified as idiopathic or vasomotor rhinitis. This high percentage of idiopathic aetiology is, at least in part, due to the fact that nasal cytology is very rarely performed. Indeed, nasal cytology only allows to recognize and identify the different NAR types on the basis of the particular inflammatory cell infiltrate (5) . In this regard, three main types ofNAR characterized by distinct inflammatory cell infiltrate have been defined: NAR infiltrated by eosinophils (i.e. non-allergic rhinitis with eosinophils, NARES), by mast cells (i.e. non-allergic rhinitis with mast cells, NARMA), and by neutrophils (i.e. non-allergic rhinitis with neutrophils, NARNE). These forms of NAR are characterized by a local inflammation that appears to be the main underlying pathogenetic mechanism (6) .
NARES is characterized by a profound nasal eosinophilia (>20% of the cells present in the mucosa), not associated with allergic disease (7) . NARES may be prevalent in up to one-third of adults, and in severe cases may be associated with non-lgE-mediated asthma, aspirin intolerance and nasal polyps (8) . NARMA was initially described by Connell and is characterized by a predominant mast cell infiltration (9) . NARNE is characterized by predominant neutrophilic inflammation without infections; its aetiology is multi-factorial, including cystic fibrosis, antro-choanal polyp, pollution, tobacco smoke, etc. (l0-12).
A fourth type of NAR is characterized by contemporaneous infiltration of eosinophils and mast cells: non-allergic rhinitis with eosinophils and mast cells, NARESMA. The aim of this study is to define the clinical and functional features of this new particular type of NAR, comparing it with the well-known types, such as NARES, NARMA, and NARNE.
MATERIALS AND METHODS

Study design
This prospective study included patients with NAR consecutively visiting the ENT Clinic of Bari (Italy). Subjects with acute upper respiratory infections, anatomic nasal defects (i.e. septum deviation), using nasal or oral corticosteroids, nasal or oral decongestants, antileukotrienes, and antihistamines during the previous 4 weeks were excluded. The diagnosis of NAR was made on the basis of a history of nasal symptoms (including sneezing, rhinorrhea, and nasal obstruction typically dependent on exposure to triggers such as odors, irritants, weather changes), presence of inflammatory cells on nasal smear, and negative skin prick test according to validated criteria (2-3).
Skin prick tests, nasal endoscopy, rhinomanometry, and Quality of Life (QoL) evaluation by questionnaire were carried out on all subjects. The study was approved by the Institutional Review Board ofthe University ofBari and informed consent was obtained from all patients.
Skin prick test
Allergy was assessed by the presence of sensitization to the most common classes of aeroallergens by performing skin prick tests. They were performed as stated by the European Academy of Allergy and Clinical Immunology: sensitization was considered when the wheal diameter was equal or greater than 3 mm (13 
Nasal cytology
Cytological samples were obtained by scraping with a Rhino-Probe'P'. The samples were collected from the medial portion of the inferior middle turbinate. After fixing with absolute alcohol for 3 minutes and drying, the samples were stained using the May-GrunwaldGiemsa (Carlo Erba, Milan, Italy) method, then mounted on covered slides and examined under microscopy (Nikon E600, Nikon Italy). Cell count was performed on 10 microscopic samples at high-power magnification (xIOOO) in immersion (14) . Samples were examined blindly by two different investigators.
NARES ( Fig. IA) was diagnosed if nasal eosinophils were >20% of total cells recovered from nasal scraping, including both inflammatory and epithelial cells;NARMA ( 
Rhinomanometry
Nasal airflow resistance was measured by active anterior electronic rhinomanometry. Patientswore a tightfitting facemask, and breathed through one nostril with their mouth closed. A sensor, placed in the controlateral nostril, recorded data on pre-and post-nasal pressures via airflow and pressure transducers. The instrument (Rhinomanometer Menfis, Amplifon Italy) was connected to a personal computer. The signals of transnasal airflow and pressure were amplified, digitalized, and saved for statistical analysis.
Nasal resistance is measured as PaimLisec (Pascal) as the sum of the recorded airflow in milliliter per second through the right and left nostrils at a pressure difference of 150 Pa across the nasal passage. Four or more airflow measurements were performed for each patient and the mean value was recorded when reproducible values were achieved. Normal values are < 0.50 PaimLisec (16) .
Quality ofLife
QoL assessment was performed by a disease-specific instrument. It was the Health-Related Quality of Life in Rhino Surgery (HRQL-RS), validated (17) , translated and adapted for use in the Italian population. This specific health profile HRQL-RS questionnaire consists of 25 items summarized in 6 dimensions: nasal and non-nasal symptoms, sleep, emotional symptoms, headache, and practical problems, these last three were summarised in a single dimension: social problems. Responses to the items are scored on a 4-point scale, the lower the score, the better the QoL. Most items are the same used in the Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ) provided by Juniper and colleagues (18) . Moreover, a visual analogue scale for QoL assessing(from O=worst QoL to lO=best QoL) was given to measure the patients' general feelings related to their nasal disease.
Statistical analysis
Data were described as mean and standard deviation. Continuous variables and categorical variables were compared by means of the Kruskall Wallis test (nonparametricanalysis of variance) and the Mann WhitneyU test for post-hoc comparisons. Kolmogorov-Smimov test was used to compare nasal resistancevalues. Correlations were evaluatedby the Spearmantest. Q2 and G 2 tests were used to compare the frequency and onset age of polyps to NAR subsets. SPSS softwarewas used for computation. A p-value<0.05 was consideredstatisticallysignificant.
RESULTS
A total of 176 patients (92 males and 84 females) with NAR were consecutively evaluated: their characteristics are reported in Table I . All were negative to skin prick tests. They were grouped according to diagnosis, such as the type of infiltrating inflammatory cells: 52 patients with NARES, 38 with NARMA, 36 with NARNE, and 50 with NARESMA ( Fig. 1) .
Quality ofLife
Globally there was a significant difference (Table lIb) . The comparison between NARES and NARESMA showed that NARESMA patients had the worst QoL for sleep dimension (p=0.017) ( Table lIb) . The analysis of single items ofthe nasal symptom dimensions revealed that NARESMA patients had a more intense impairment for dry nose, snoring and sore throat (p<0.001, p=0.005, and p=0.026, respectively), whereas NARES patients showed more severe post nasal drip (p=0.004) (Table lIe) . Moreover, there was a significant relationship between nasal obstruction and snoring, and between nasal obstruction and sore throat only in NARESMA and NARES patients (Table IlIa) . In addition, a relationship between Qol assessed by VAS and all dimensions existed only for NARESMA and between QoL-VAS and social problems in NARMA (Table I1Ib) . Snoring and nocturnal awakening were more frequent in NARESMA patients compared to other groups, as reported in Fig. 2 .
Clinical features
The association with nasal polyposis was more frequent in NARESMA and NARES patients in comparison with other groups (Table IVa) , however the association with asthma was more evident in NARESMA patients (Table IVb) .
Relationship between QoL and rhinomanometry
A significant association was noted only for 
s (A), mastcells (B), neutrophi/s (C), and mast cells associated with eosinophi/s (D). Magnification IOOOx
NARESMA concerning social problems (p=O.002), sleep (p=O.006), and non-nasal symptoms (p=O.009) (Fig. 3) .
DISCUSSION
NAR diagnosis is based on two main features in patients with nasal symptoms consequent to exposure to irritants: negative skin prick test and cytological This study confirms previous findings and provides clear evidence that NARESMA constitutes a new particular type ofNAR.
Patients with NARESMA had the worst QoL for most dimensions, thus underlining the severity of this form. Moreover, this clinical aspect is confirmed by functional findings: the nasal resistance is higher in this group compared to the others. This issue highlights the importance of the nasal obstruction in determining the severity of NARs. Indeed, nasal obstruction clearly determines the occurrence of snoring, nocturnal awakening, sore throat, and dry nose as oral respiration arises.
In addition, NARESMA is frequently associated with nasal polyposis: this phenomenon underlines the severity of this form as polyps are a typical consequence of mucosal inflammation. Finally, NARESMA alone is significantly associated with asthma. This issue allows to understand type of NAR and is more severe than others as demonstrated by worst QoL, increased nasal resistances, frequent association with nasal polyps and asthma. Eosinophilic infiltrate consequently induces severe inflammation that causes the most severe symptoms. Indeed, eosinophil inflammation is the best marker of allergic inflammation (20) . Moreover, eosinophils are also the main inflammatory cells that infiltrate nasal polyps (21) . Inflammatory oedema associated with polyp formation contributes to the impairment of nasal airflow. In this regard, nasal obstruction is a crucial symptom that allows the occurrence of several complications (22) . In addition, mast cells represent a relevant source for mediator release, mainly histamine and leukotrienes, both of which cause vasodilatation, increased vessel permeability, and stimulation of nerves causing the appearance of symptoms.
Moreover, the contemporaneous presence of two inflammatory cell types appears to be crucial in determining the severity of nasal symptoms that may be evaluated both by QoL questionnaires and rhinomanometry.
In conclusion, this study provides the first evidence that NARESMA is a new distinct type ofNAR and is particularly severe, and it must besuspected in patients with severe symptoms and with polyps and/or asthma. Moreover, nasal cytology appears a crucial diagnostic tool to diagnose and mana~e NARs. the close relationship between upper and lower airways, as recently reported (19) . In this regard, the concurrent presence of NARESMA, nasal polyps, and asthma may represent a prognostic factor of relapse after polypectomy (manuscript in preparation). Therefore, this study provides the first evidence that NARESMA is a distinct
